Virulent HIV strains, chimpanzees, and trial vaccines

Authors

Alfred M. Prince, Laboratory of Virology, New York Blood Center
Jonathan Allan, Southwest Foundation for Biomedical Research
Linda Andrus, New York Blood Center
Betsy Brotman, Vilab II, Liberian Institute for Biomedical Research
Jorg Eichberg, Journal of Medical Primatology
Roger Fouts, Central Washington University
Jane Goodall, Jane Goodall Institute for Wildlife Research, Education, and Conservation
Preston Marx, Tulane University Medical Center
Krishna K. Murthy, Southwest Foundation for Biomedical Research
Shirley McGreal, International Primate Protection League
Carole Noon, Chimpanzee Sanctuary, Center for Captive Chimpanzee Care

Document Type

Article

Department or Administrative Unit

Primate Behavior and Ecology

Publication Date

2-19-1999

Abstract

We would like to comment on the controversy concerning the use of a virulent strain of human immunodeficiency virus (HIV) to assess the protective efficacy of candidate HIV vaccines (A. M. Prince and L. Andrus, Letters, Science's Compass, 18 Dec., p. 2195; N. L. Letvin, ibid.). We believe that this must be viewed from both scientific and ethical perspectives.

Comments

This article was originally published in Science. The full-text article can be found here.

Due to copyright restrictions, this article is not available for free download from ScholarWorks @ CWU.

Recommended Citation

Prince, A. M., et al, (1999). Virulent HIV Strains, Chimpanzees, and Trial Vaccines. Science, 283(5405), 1115. https://doi.org/10.1126/science.283.5405.1115e

Journal

Science

Rights

© 1999 American Association for the Advancement of Science